Pfizer: If vaccine-escape variant emerges, expects to develop, produce new vaccine in about 100 days


According to vaccine-maker Pfizer, in case there was a "vaccine-escape" variant, the company expects to be able to develop and produce a new tailor-made vaccine against that variant within about 100 days.  

Market Reaction

The comments from Pfizer have offered little solace to a still overall very risk-off market. 100 days for a vaccine is good, but then nations would have to roll the vaccine out, which as seen in 2021, takes many months.

A vaccine-resistant variant, if that is what the new South African variant turns out to be, could still deliver a significant blow to the global economic outlook over the next six months if nations significantly tighten lockdowns and travel restrictions and consumers begin to fear the virus again. 

Note: All information on this page is subject to change. The use of this website constitutes acceptance of our user agreement. Please read our privacy policy and legal disclaimer. Opinions expressed at FXstreet.com are those of the individual authors and do not necessarily represent the opinion of FXstreet.com or its management. Risk Disclosure: Trading foreign exchange on margin carries a high level of risk, and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. Before deciding to invest in foreign exchange you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain a loss of some or all of your initial investment and therefore you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with foreign exchange trading, and seek advice from an independent financial advisor if you have any doubts.

Feed news Join Telegram

Recommended content


Recommended content

Editors’ Picks

EUR/USD stays below 1.0400 on soft EU inflation data

EUR/USD stays below 1.0400 on soft EU inflation data

EUR/USD clings to modest daily gains above 1.0350 during the European trading hours. Eurostat reported that annual Core HICP remained steady at 5% in the Eurozone in November as expected. Investors await key data releases from the US and Powell's speech.

EUR/USD News

GBP/USD recovers from 1.1940 as US Dollar refreshes day’s low, Fed Powell’s speech eyed

GBP/USD recovers from 1.1940 as US Dollar refreshes day’s low, Fed Powell’s speech eyed

GBP/USD has sensed responsive buying action around 1.1940 as risk aversion loses luster. The Bank of England is expected to advance its interest rates to 4.25% in Q1CY2023. GBP/USD has gained strength after testing the 200-EMA around 1.1960.

GBPUSD News

Gold bulls seek validation from $1,760 and Fed Chair Powell

Gold bulls seek validation from $1,760 and Fed Chair Powell

Gold price remains firmer for the second consecutive day, bounces off 10-DMA, short-term key support. Fed Powell’s first speech after November, hawkish hopes tease Gold sellers.

Gold News

Three on-chain metrics suggest Bitcoin price has bottomed, here’s where BTC is going next

Three on-chain metrics suggest Bitcoin price has bottomed, here’s where BTC is going next

Bitcoin price action has spiked 5% over the last 24 hours, hinting at the start of an optimistic scenario. Previous publications have already explored why BTC is ready for a bear market rally from both short-term and long-term outlooks.

Read more

ADP Jobs Preview: Markets set to find more reasons to sell the Dollar, big beat needed to boost it Premium

ADP Jobs Preview: Markets set to find more reasons to sell the Dollar, big beat needed to boost it

ADP's jobs report has finally come in line with the official NFP report. It took a hiatus and a change in formula to make that happen, but what matters is that this release finally matters. 

Read more

Forex MAJORS

Cryptocurrencies

Signatures